The CDC is warning health care providers that the number of dengue cases in the U.S. is on the rise

The US Centers for Disease Control and Prevention (CDC) issued a warning to health care providers on Tuesday about the increased risk of dengue virus infections in the United States.

Cases of the mosquito-borne viral disease have hit a record high in the United States this year, the agency said, echoing a similar report by the World Health Organization last month.

The CDC said the number of dengue cases in the United States exceeded 9.7 million between January 1 and June 24, more than doubling by 2023.

The agency has urged health providers to take measures such as preventive measures, appropriate diagnostic tests and timely reporting of dengue cases to public health authorities to control the spread of the infection.

Last month, the WHO “pre-qualified” Takeda Pharmaceuticals’ Qdenga dengue vaccine, making it eligible for purchase by UN agencies such as Unicef ​​and the Pan American Health Organization.

Qdenga is approved in countries such as the European Union, Indonesia, Thailand, Argentina and Brazil.

French pharmaceutical company Sanofi’s Dengvaxia is approved in several countries in the US, Europe and Asia.